Ulti_1170x120_5-11-20

Zephrex-D

Perrigo licenses meth-resistant tech for PSE products

Perrigo licenses meth-resistant tech for PSE products

DUBLIN, Ireland — Perrigo Co. plc is bringing in methamphetamine-blocking capability for pseudoephedrine (PSE) products. On Tuesday, Perrigo said it has entered an exclusive licensing agreement with St. Louis-based Highland Pharmaceuticals for its Tarex meth-blocking technology. The deal also includes the distribution rights of Zephrex-D, the pseudoephedrine nasal decongestant marketed by Highland’s Westport Pharmaceuticals unit.

Indiana pharmacists: Bill keeps PSE meds OTC

Indiana pharmacists: Bill keeps PSE meds OTC

Pharmacists in Indiana are backing state legislation that would uphold over-the-counter access to medicines containing pseudoephedrine (PSE) while reining in illicit use of these products for methamphetamine production. Community Pharmacies of Indiana (CPI) is supporting Indiana Senate Bill 80 (SB80), also known as the Pharmacist Legitimization Bill. CPI said the measure aims to control the sale